{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:08:42Z","timestamp":1791558522959,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.autrev.2015.08.003","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T03:19:29Z","timestamp":1438831169000},"page":"1142-1146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Auto-reactions, autoimmunity and psoriatic arthritis"],"prefix":"10.1016","volume":"14","author":[{"given":"Maria Sole","family":"Chimenti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Triggianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Nuccetelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Crisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Domenica","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.08.003_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2012.10.002","article-title":"Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways","volume":"12","author":"Chimenti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0010","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.autrev.2015.05.010","article-title":"Measuring psoriatic disease in clinical practice. An expert opinion position paper","volume":"14","author":"Lubrano","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0015","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.08.003_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.08.003_bb0025","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.08.003_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.61.6.534","article-title":"Histological assessment of the early enthesitis lesion in spondyloarthropathy","volume":"61","author":"McGonagle","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.08.003_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","article-title":"Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy","volume":"13","author":"van Kuijk","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2015.08.003_bb0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.autrev.2014.08.012","article-title":"Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment","volume":"13","author":"Sakkas","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.autrev.2014.10.012","article-title":"Regulatory T-cells in autoimmune diseases: challenges, controversies and\u2014yet\u2014unanswered questions","volume":"14","author":"Grant","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"Suppl. 1","key":"10.1016\/j.autrev.2015.08.003_bb0060","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2886","article-title":"Type I interferon in organ-targeted autoimmune and inflammatory diseases","volume":"12","author":"Crow","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.08.003_bb0065","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/eji.201242653","article-title":"IL-17: a new actor in IFN-driven systemic autoimmune diseases","volume":"42","author":"Ambrosi","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat Med"},{"issue":"72","key":"10.1016\/j.autrev.2015.08.003_bb0075","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"1","author":"Frey","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.08.003_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar2580","article-title":"Psoriatic arthritis: from pathogenesis to therapy","volume":"11","author":"Fitzgerald","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.08.003_bb0085","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.172.3.1935","volume":"172","author":"Curran","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0090","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2015.08.003_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","article-title":"Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis","volume":"60","author":"Tassiulas","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0100","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1529-0131(199803)41:3<453::AID-ART11>3.0.CO;2-#","article-title":"Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation","volume":"41","author":"Snowden","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.08.003_bb0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Ca\u00f1ete","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.08.003_bb0110","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.autrev.2014.11.012","article-title":"T cell responses in psoriasis and psoriasi arthritis","volume":"14","author":"Diani","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0115","first-page":"330","article-title":"Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices","volume":"33","author":"Bandinelli","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0120","doi-asserted-by":"crossref","first-page":"e115424","DOI":"10.1371\/journal.pone.0115424","article-title":"Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis","volume":"9","author":"Dolcino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2015.08.003_bb0125","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2015.08.003_bb0130","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.4049\/jimmunol.1000075","article-title":"Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis","volume":"184","author":"Mydel","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.autrev.2015.01.017","article-title":"Autoantibodies 2015: from diagnostic biomarkers toward prediction, prognosis and prevention","volume":"14","author":"Damoiseaux","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"Shi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0145","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.autrev.2015.03.002","article-title":"Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity","volume":"14","author":"Pinegin","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0150","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.08.003_bb0155","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.biochi.2012.06.032","article-title":"Carbamoylated free amino acids in uremia: HOCl generates volatile protein modifying and cytotoxic oxidant species from N-carbamoyl-threonine but not threonine","volume":"94","author":"Schreirer","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.autrev.2015.08.003_bb0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.matbio.2006.10.008","article-title":"Carbamylation differentially alters type I collagen sensitivity to various collagenases","volume":"26","author":"Jaisson","year":"2007","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2015.08.003_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","article-title":"Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage","volume":"17","author":"Brink","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.08.003_bb9000","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.autrev.2015.08.003_bb9005","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12026-014-8560-x","article-title":"Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis","volume":"61","author":"Yee","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.autrev.2015.08.003_bb0170","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.08.003_bb0175","doi-asserted-by":"crossref","first-page":"e005246","DOI":"10.1136\/bmjopen-2014-005246","article-title":"Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study","volume":"4","author":"Hafstr\u00f6m","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2015.08.003_bb0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-152-7-201004060-00010","article-title":"Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosing rheumatoid arthritis","volume":"152","author":"Whiting","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2015.08.003_bb0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11739-015-1206-8","article-title":"The challenge of using the rheumatoid arthritis diagnostic criteria in clinical practice","volume":"10","author":"Corrao","year":"2015","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.autrev.2015.08.003_bb0190","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"van de Stadt LA","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.08.003_bb0195","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1136\/annrheumdis-2013-203650","article-title":"Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients","volume":"72","author":"Hissink Muller","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.08.003_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/15376516.2011.556155","article-title":"The effect of the uremic toxin cyanate (CNO-) on anaerobic cysteine metabolism and oxidative processes in the rat liver: a protective effect of lipoate","volume":"21","author":"Sokolowska","year":"2011","journal-title":"Toxicol Mech Methods"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721500169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721500169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T12:22:19Z","timestamp":1537446139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721500169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S156899721500169X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.08.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Auto-reactions, autoimmunity and psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}